DR. DEVLEESCHOUWER DIRK
ActiveSummary
DR. DEVLEESCHOUWER DIRK has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €744,489 and a net result of €112,722. Equity is growing by about 9.9% per year across the filed financial years. Its solvency ranks better than 60% of 615 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
26-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
27-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 27 days late
2024
31-12
Financial
Highest result from 2018 to 2025net €114,781 ▲17.4%
Operating result €186,325, net result €114,781, both a record.
27-09
NBB filing
Annual accounts filed
financial year 2023 · micro format · 58 days late
2023
31-12
Financial
Equity above €500,000equity €516,986 ▲23.3%
A profit in every financial year since 2018 builds equity to €516,986.
25-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
25-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 25 days late
2021
31-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 31 days late
2020
28-09
NBB filing
Annual accounts filed
financial year 2019 · micro format · 59 days late
2019
27-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 27 days late
2018
29-08
NBB filing
Annual accounts filed
financial year 2017 · micro format · 29 days late
2017
29-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 24 annual accounts filed, the latest 10 are here; all 24 are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.